A comparison of multiple dose pharmacokinetic profiles of biphasic insulin aspart 30 and 70 in adults with Type 1 diabetes.

被引：0
|
作者：
Chen, J
Christiansen, JS
Jensen, LH
机构：
[1] Aarhus Cty Hosp, Med Dept M, Aarhus, Denmark
[2] Novo Nordisk AS, Bagsvaerd, Denmark
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
744
引用
收藏
页码：A239 / A239
页数：1
相关论文
共 50 条
  • [1] Modeling of Pharmacokinetic Profiles of Insulin Aspart and Biphasic Insulin Aspart 30/70
    Kulesh, Victoria S.
    Drai, Roman, V
    Zinnatulina, Bella R.
    Makarenko, Igor E.
    Pilyus, Fedor G.
    Khokhlov, Alexander L.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (09): : 1086 - 1093
  • [2] Pharmacokinetic profiles of biphasic insulin aspart 30/70 and 70/30 in patients with Type 1 diabetes: a randomized double-blinded crossover study
    Chen, JW
    Lauritzen, T
    Christiansen, JJ
    Jensen, LH
    Clausen, WHO
    Christiansen, JS
    [J]. DIABETIC MEDICINE, 2005, 22 (03) : 273 - 277
  • [3] A comparison of pharmocodynamics and pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 & Pure Insulin Aspart in type 1 diabetes
    Thorisdottir, Rannveig L.
    Parkner, Tina
    Chen, Jian-Wen
    Ejskjaer, Niels
    Christiansen, Jens S.
    [J]. DIABETES, 2007, 56 : A555 - A555
  • [4] Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
    Valensi, Paul
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2009, 2 : 61 - 71
  • [5] Pharmacokinetics and glucodynamics of Biphasic Insulin Aspart 30 and 50 in Japanese Type 2 diabetes.
    Hirao, K
    Maeda, H
    Urata, S
    Takisawa, Y
    Hirao, S
    Kageyama, S
    [J]. DIABETOLOGIA, 2003, 46 : A269 - A270
  • [6] Comparison of biphasic insulin aspart and human insulin including biphasic human insulin in adolescents with type 1 diabetes. A safety and efficacy trial
    Mortensen, H
    Kocova, M
    Bruckner, I
    Philotheou, A
    Weinreich, V
    Keiding, J
    [J]. DIABETES, 2003, 52 : A564 - A564
  • [7] The pharmacokinetic and pharmacodynamic properties of biphasic insulin aspart 70 (BIAsp 70) are significantly different from those of biphasic insulin aspart 30 (BIAsp 30)
    Bott, S
    Tusek, C
    Heinemann, L
    Friberg, HH
    Heise, T
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (09) : 545 - 550
  • [8] Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus
    Velasquez-Mieyer, Pedro A.
    Neira, Claudia P.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2377 - 2382
  • [9] Biphasic insulin aspart and biphasic human insulin in type 2 diabetes: A comparison
    Jacobsen, LV
    Bell, PM
    McSorely, P
    Kristensen, A
    [J]. DIABETES, 2000, 49 : A112 - A112
  • [10] Pharmacokinetic and pharmacodynamic differences between premixed suspensions of insulin aspart: biphasic insulin aspart 30, 50 and 70
    Heise, T
    Kapitza, C
    Jacobsen, LV
    Brondsted, L
    Heinemann, L
    [J]. DIABETOLOGIA, 2005, 48 : A301 - A301
12345